Quadria Capital acquires minority stake in NephroPlus for $102 million

"The transaction will support NephroPlus in serving the growing demand for high quality, affordable dialysis services across India and other markets in Asia," Singapore-headquartered Quadria said

Divestment, privatisation, stake sale, disinvestment
NephroPlus operates about 450 dialysis centres and operates in three main countries namely India, the Philippines and Uzbekistan.
Reuters
1 min read Last Updated : May 06 2024 | 4:53 PM IST
Quadria Capital on Monday said it has invested $102 million in India's largest dialysis chain NephroPlus, picking up a minority stake in the company as the Asia-focussed private equity firm keeps investing in regional healthcare providers.
 
"The transaction will support NephroPlus in serving the growing demand for high quality, affordable dialysis services across India and other markets in Asia," Singapore-headquartered Quadria said.
 
The PE firm expects demand for dialysis, a blood purifying treatment for kidney disorders, to grow over the next five in the markets it is targeting to grow.
 
The Economic Times on Friday reported that the fresh investment values NephroPlus at more than $239.6 million.
 
NephroPlus operates about 450 dialysis centres and operates in three main countries namely India, the Philippines and Uzbekistan.
 
Quadria, which manages total assets of over $3.4 billion, has in the past invested in other Indian healthcare providers including eye-care chain Maxivision and oncology network HCG.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Private EquityNephroPlus

First Published: May 06 2024 | 4:53 PM IST

Next Story